RecruitingNot ApplicableNCT05999006

Safety and Feasibility of the ELIOS System in POAG Patients

A Prospective, Multicenter, Clinical Trial Designed to Evaluate the Safety and Feasibility of the ELIOS System to Reduce Intraocular Pressure in Patients With Primary Open-Angle Glaucoma as a Standalone Procedure


Sponsor

Elios Vision, Inc.

Enrollment

65 participants

Start Date

Oct 18, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)


Eligibility

Min Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study tests the safety and practicality of a new device called the ELIOS System for treating glaucoma — a condition where increased pressure in the eye damages the optic nerve and can lead to vision loss. **You may be eligible if...** - You have been diagnosed with mild to moderate primary open-angle glaucoma (the most common type) - Your eye pressure is reasonably controlled on medication (24 mmHg or below) - Your eye anatomy (the angle and optic nerve) meets specific criteria for the device - You are at least 45 years old **You may NOT be eligible if...** - You have a different type of glaucoma (such as closed-angle or secondary glaucoma) - You have had previous eye surgery (for glaucoma, cataracts, or corneal conditions) - You are pregnant or nursing, or of childbearing age without reliable contraception - You are a known steroid responder (your eye pressure rises with steroid eye drops) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEELIOS Procedure

Treatment with the ELIOS System


Locations(5)

Elios Vision Clinical Site

Glendale, Arizona, United States

Elios Vision Clinical Site

Largo, Florida, United States

Elios Vision Clinical Site

Rock Island, Illinois, United States

Elios Vision Clinical Site

Oklahoma City, Oklahoma, United States

Elios Vision Clinical Site

Kenosha, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05999006


Related Trials